JPS63198629A - 高血圧予防・治療剤 - Google Patents

高血圧予防・治療剤

Info

Publication number
JPS63198629A
JPS63198629A JP62031233A JP3123387A JPS63198629A JP S63198629 A JPS63198629 A JP S63198629A JP 62031233 A JP62031233 A JP 62031233A JP 3123387 A JP3123387 A JP 3123387A JP S63198629 A JPS63198629 A JP S63198629A
Authority
JP
Japan
Prior art keywords
calcium
hypertension
phosphate
substance
hexose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62031233A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0521089B2 (enExample
Inventor
Shoichi Murata
昌一 村田
Yoshinao Nagashima
義直 永嶋
Kenji Hara
健次 原
Shigeto Kayane
滋人 茅根
Takashi Imamura
孝 今村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP62031233A priority Critical patent/JPS63198629A/ja
Priority to US07/155,509 priority patent/US4983582A/en
Publication of JPS63198629A publication Critical patent/JPS63198629A/ja
Publication of JPH0521089B2 publication Critical patent/JPH0521089B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP62031233A 1987-02-13 1987-02-13 高血圧予防・治療剤 Granted JPS63198629A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP62031233A JPS63198629A (ja) 1987-02-13 1987-02-13 高血圧予防・治療剤
US07/155,509 US4983582A (en) 1987-02-13 1988-02-12 Preventive and therapeutic method for hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62031233A JPS63198629A (ja) 1987-02-13 1987-02-13 高血圧予防・治療剤

Publications (2)

Publication Number Publication Date
JPS63198629A true JPS63198629A (ja) 1988-08-17
JPH0521089B2 JPH0521089B2 (enExample) 1993-03-23

Family

ID=12325691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62031233A Granted JPS63198629A (ja) 1987-02-13 1987-02-13 高血圧予防・治療剤

Country Status (2)

Country Link
US (1) US4983582A (enExample)
JP (1) JPS63198629A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356879A (en) * 1992-02-14 1994-10-18 Biospherics, Incorporated D-tagatose as anti-hyperglycemic agent
US8440619B2 (en) * 2005-08-31 2013-05-14 National University Corporation Kagawa University Utilization of hypertension/hypercardia-preventing effect of D-allose

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1351134A (fr) * 1962-03-15 1964-01-31 Colonial Sugar Refining Co Procédé de fabrication d'esters phosphoriques d'hydrates de carbone et d'alcools polyhydriques
FR3096M (fr) * 1963-07-09 1965-02-01 Roussel Uclaf Nouveau médicament notamment pour le traitement des états d'adynamie.
DE1468875A1 (de) * 1964-06-24 1970-10-22 Roussel Uclaf Verfahren zur Herstellung eines neuen Salzes der Glucose-1-phosphorsaeure
GB1134062A (en) * 1964-11-25 1968-11-20 Colonial Sugar Refining Co Water-soluble phosphate compositions and process for preparing
FR5145M (enExample) * 1966-05-03 1967-06-05
SU454911A1 (ru) * 1969-11-19 1974-12-30 Ленинградский Ордена Трудового Красного Знамени Научно-Исследовательский Институт Гематологии И Переливания Крови Средство, повышающее уровень энергетического обмена организма "гексозофосфат"
US4006134A (en) * 1970-09-07 1977-02-01 Imperial Chemical Industries Limited Calcium sugar phosphates
US3931402A (en) * 1970-12-02 1976-01-06 Societa Prodotti Antibiotici S.P.A. Preparations containing hexoses
BE794136A (fr) * 1972-01-19 1973-07-17 Roussel Uclaf Procede de preparation de sels de l'acide alpha-d-glucose-1- phosphorique et produits obtenus
DE2518888C3 (de) * 1975-04-28 1980-07-03 Lentia Gmbh, Chem. U. Pharm. Erzeugnisse - Industriebedarf, 8000 Muenchen Verwendung einer Infusionslösung bestimmter Zusammensetzung bei der Therapie mittels forcierter Diurese
DE2629845A1 (de) * 1976-07-02 1978-01-05 Geb Graze Erika Graze Infusions- bzw. injektionsloesungen bzw. waessrige konzentrate zu deren bereitung zur therapeutischen restituion des zellulaeren energiestoffwechsels und der koerpereigenen regelfunktion
JPS57145899A (en) * 1981-03-05 1982-09-09 Wakunaga Yakuhin Kk Steroid saponin and its preparation
JPS60130523A (ja) * 1983-12-16 1985-07-12 Yamasa Shoyu Co Ltd アルギン酸カルシウムを有効成分とする経口医療補助組成物

Also Published As

Publication number Publication date
US4983582A (en) 1991-01-08
JPH0521089B2 (enExample) 1993-03-23

Similar Documents

Publication Publication Date Title
EP1089726B1 (en) Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid
US4435449A (en) Treatment of minimal brain dysfunction (MBD)
WO2016188091A1 (zh) 烟酰胺单核苷酸在制备防治动脉硬化、心脑血管疾病的药物中的应用及其药物
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
US5182112A (en) Antidiarrheal compositions containing laperamide hydrochloride and a saccharide
KR20240032789A (ko) 시클로-히스프로를 유효성분으로 포함하는 비만 예방 또는 치료용 약제학적 조성물
EP0629400A1 (en) Idebenone compositions for treating Alzheimer's disease
EP1093817B1 (en) Composition containing compounds with adrenergic activity and vegetable extracts of crataegus and gingko biloba for the treatment of overweight and obesity
RU2110254C1 (ru) Композиция для профилактики и лечения гриппа и орви
JPS63198629A (ja) 高血圧予防・治療剤
JPH0358328B2 (enExample)
NZ217431A (en) Synergistically antimalarial combination preparations comprising an iron(iii) chelating agent and a schizontocide
NL8105635A (nl) Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
KR100562739B1 (ko) 저알부민 상태의 개선제
EP1362593B1 (en) Cytidine-phosphocholine for the treatment of diabetic neuropathy
EP0342211B1 (en) Treatment of arteriosclerosis by administration of l-tryptophan or l-5-hydroxytryptophan
JPS63198630A (ja) 脂質代謝改善剤
Ogihara et al. Dose-effect relationship of carvedilol in essential hypertension: an open study
GB1584089A (en) Antihypertensive pharmaceutical compositions
JPH0518811B2 (enExample)
KR100816140B1 (ko) 일차성 두통의 치료에서 비타민 혼합물의 용도
Bloomfield et al. Guanadrel and guanethidine in hypertension
JPH01221316A (ja) 脳循環代謝改善剤
US3932652A (en) Antidepressant compositions
US3914425A (en) Antitussive codeine composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees